CYCLERION THERAPEUTICS INC (CYCN) Institutional Ownership Changes & 13F Activity
CYCLERION THERAPEUTICS INC (CYCN). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Kalehua Capital Management Llc, Fmr Llc, Balyasny Asset Management L.P., Adar1 Capital Management, Llc, and Braidwell Lp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +101,329 | +554.9% | 119,590 | $405.41K | Q2 2026 | Sep 02, 2026 |
| Kalehua Capital Management Llc | Buy | +3,302,700 | — | 3,302,700 | $11.20M | Q2 2026 | Aug 19, 2026 |
| Balyasny Asset Management L.P. | Buy | +317,511 | — | 317,511 | $1.08M | Q2 2026 | Aug 14, 2026 |
| Adar1 Capital Management, Llc | Buy | +298,757 | — | 298,757 | $1.01M | Q2 2026 | Aug 14, 2026 |
| Braidwell Lp | Buy | +156,890 | — | 156,890 | $531.86K | Q2 2026 | Aug 14, 2026 |
| Rangeley Capital, Llc | Buy | +24,310 | — | 24,310 | $82.41K | Q2 2026 | Aug 14, 2026 |
| Hrt Financial Lp | Buy | +22,054 | — | 22,054 | $74.00K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +87 | — | 87 | $295.00 | Q2 2026 | Aug 14, 2026 |
| Fmr Llc | Buy | +644,807 | +13603.5% | 649,547 | $2.20M | Q2 2026 | Aug 13, 2026 |
| Vanguard Capital Management Llc | Buy | +14,778 | +91.6% | 30,915 | $104.80K | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -256 | -7.5% | 3,135 | $10.63K | Q2 2026 | Aug 13, 2026 |
| Bnp Paribas Financial Markets | Sell | -1 | -20.0% | 4 | $14.00 | Q2 2026 | Aug 13, 2026 |
| Geode Capital Management, Llc | Sell | -38,700 | -45.8% | 45,850 | $155.47K | Q2 2026 | Aug 12, 2026 |
| Dimensional Fund Advisors Lp | Buy | +11,724 | — | 11,724 | $39.74K | Q2 2026 | Aug 11, 2026 |
| Tower Research Capital Llc (Trc) | Buy | +1,849 | — | 1,849 | $6.27K | Q2 2026 | Aug 11, 2026 |
| Mai Capital Management | Sell | -100 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Morgan Stanley | Sell | -1 | -100.0% | 0 | $0.00 | Q2 2026 | May 15, 2026 |
| Kovack Advisors, Inc. | Sell | -10,000 | -100.0% | 0 | $0.00 | Q2 2026 | May 13, 2026 |
| Citigroup Inc | Sell | -89 | -100.0% | 0 | $0.00 | Q2 2026 | May 11, 2026 |
| Caitong International Asset Management Co., Ltd | Sell | -4 | -100.0% | 0 | $0.00 | Q2 2026 | May 11, 2026 |
Frequently asked questions about CYCN activity
Which institutional owners are buying CYCN?
Institutional owners buying CYCN include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in CYCN activity?
"Buy" means an investor increased their reported position in CYCN compared to the prior reporting period. This reflects growing exposure to CYCLERION THERAPEUTICS INC (CYCN) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in CYCN increasing?
Institutional interest in CYCN can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related CYCN Institutional Insights
- CYCN Overview
- CYCN 13F Institutional Holders
- CYCN Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- CYCN Insider Trading & SEC Form 4 Activity
- CYCN Articles
- Top Institutional Investor Stock Rankings